Skip to content

PERFORMANT HEALTHCARE, INC.: financial reference

Explore PERFORMANT HEALTHCARE, INC. financial histories from SEC filings, with original units, reporting periods, filing dates and downloadable source data.

Reported financial histories

Choose a measure to inspect its definition, complete selected history and filing provenance. Each row shows the latest period available for that selected concept and original unit. Separate currencies and reporting intervals remain separate rows. Coverage dates can differ between concepts. A recent capture does not imply recent accounting coverage; these amounts are not prices.

Latest periods by selected concept and original unit
MeasurePeriod startPeriod endValueUnitFiled
Total assetsAt date2024-12-31101,774,000USD2025-03-13
Total liabilitiesAt date2024-12-3125,275,000USD2025-03-13
Stockholders equityAt date2024-12-3176,499,000USD2025-03-13
Cash and cash equivalentsAt date2024-12-319,292,000USD2025-03-13
Net income or loss2024-01-012024-12-31-9,895,000USD2025-03-13
Operating cash flow2024-01-012024-12-316,178,000USD2025-03-13
Capital expenditure payments2024-01-012024-12-317,010,000USD2025-03-13
Revenue2021-01-012021-12-31124,393,000USD2022-03-16
Contract revenue excluding tax2024-01-012024-12-31122,981,000USD2025-03-13
Financing cash flow2024-01-012024-12-312,791,000USD2025-03-13
Investing cash flow2024-01-012024-12-31-7,010,000USD2025-03-13
Retained earnings or deficitAt date2024-12-31-75,197,000USD2025-03-13
Basic weighted-average shares2024-01-012024-12-3177,500,000shares2025-03-13
Diluted weighted-average shares2024-01-012024-12-3177,500,000shares2025-03-13
Basic earnings per share2024-01-012024-12-31-0.13USD/shares2025-03-13
Diluted earnings per share2024-01-012024-12-31-0.13USD/shares2025-03-13
Income tax expense or benefit2024-01-012024-12-31-351,000USD2025-03-13
Net property, plant and equipmentAt date2024-12-3114,021,000USD2025-03-13
Share-based compensation expense2024-01-012024-12-315,881,000USD2025-03-13
Operating income or loss2024-01-012024-12-31-9,500,000USD2025-03-13
Current assetsAt date2024-12-3138,358,000USD2025-03-13
Interest expense2023-01-012023-12-311,974,000USD2024-03-13
Current liabilitiesAt date2024-12-3113,971,000USD2025-03-13
Current accounts payableAt date2024-12-31482,000USD2025-03-13
Goodwill carrying amountAt date2024-12-3147,372,000USD2025-03-13
Net finite-lived intangible assetsAt date2021-12-310USD2022-03-16
Net current accounts receivableAt date2024-12-3114,165,000USD2025-03-13
Common-stock repurchase payments2014-01-012014-12-310USD2015-03-13
Operating expenses2024-01-012024-12-31132,481,000USD2025-03-13
Common shares outstandingAt date2024-12-3178,309,000shares2025-03-13
Cash including restricted cashAt date2024-12-319,292,000USD2025-03-13
Total equity including noncontrolling interestsAt date2024-12-3176,499,000USD2025-03-13
Operating lease right-of-use assetAt date2024-12-31826,000USD2025-03-13
Operating lease liabilityAt date2024-12-31845,000USD2025-03-13
Long-term debtAt date2023-12-310USD2024-03-13
Gross property, plant and equipmentAt date2024-12-3161,892,000USD2025-03-13
Accumulated depreciation on property, plant and equipmentAt date2024-12-3147,871,000USD2025-03-13
Other noncurrent assetsAt date2024-12-31781,000USD2025-03-13
Other noncurrent liabilitiesAt date2024-12-31156,000USD2025-03-13
Accrued current liabilitiesAt date2024-12-312,000,000USD2025-03-13
Prepaid expenses and other current assetsAt date2024-12-313,991,000USD2025-03-13
Current contract liabilitiesAt date2024-12-31753,000USD2025-03-13
Net deferred tax assetsAt date2024-12-31805,000USD2025-03-13
Net deferred tax liabilitiesAt date2019-12-3135,000USD2020-04-29
Pre-tax income or loss from continuing operations2024-01-012024-12-31-10,246,000USD2025-03-13
Profit or loss including noncontrolling interests2021-01-012021-12-31-10,288,000USD2022-03-16
Comprehensive income or loss2019-01-012019-12-31-26,820,000USD2020-04-29
Net income available to common stockholders2014-01-012014-12-319,400,000USD2015-03-13
Depreciation expense2024-01-012024-12-316,600,000USD2025-03-13
Depreciation, depletion and amortization2024-01-012024-12-316,598,000USD2025-03-13
Amortization of intangible assets2021-01-012021-12-31700,000USD2022-03-16
Current income tax expense or benefit2024-01-012024-12-31-351,000USD2025-03-13
Deferred income tax expense or benefit2024-01-012024-12-310USD2025-03-13
Interest paid, net2024-01-012024-12-31670,000USD2025-03-13
Income taxes paid, net2024-01-012024-12-31-94,000USD2025-03-13
Proceeds from issuing common stock2022-01-012022-12-310USD2023-03-17
Operating lease payments2024-01-012024-12-31600,000USD2025-03-13
Change in accounts receivable2024-01-012024-12-31-3,419,000USD2025-03-13
Change in accounts payable2024-01-012024-12-31-245,000USD2025-03-13

Filings

52 PERFORMANT HEALTHCARE, filings with published measures: what each annual or quarterly report tagged, with the periods it covered, as reported in that filing. The histories above show the latest-filed value per period.

Inspect the source

Entity
PERFORMANT HEALTHCARE, INC. / CIK 0001550695
Captured
2026-09-21T17:19:49.020Z
SEC response SHA-256
1c041ade5414cb120162226f621bdbb35d9419b6670545ea2933540e75c9ff81

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001550695.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))